Anti-Carcinoembryonic Antigen (CEA)


CEA is a heterogeneous family of related oncofetal glycoproteins of molecular mass 200 kD that is secreted into the glycocalyx surface of gastrointestinal cells. Usually CEA is demonstrated as a linear labeling of the apical poles of cells lining the glandular lumen and, occasionally, as weak staining near the apex of colonic epithelial cells. CEA, however, should not be used as a marker of differentiation because many colon and lung tumors actually show increased staining with differentiation. Pancreatic carcinomas, testicular tumor, gall bladder neoplasms and granular cell myoblastomas stain positive, whereas malignant tumors of brain, prostate, skin, lymphoreticular tissues, hepatocellular carcinomas, oesophageal squamous cell carcinomas, and mesothelioma fail to stain for CEA.
Intended Use: IVD
Antibody Type: Monoclonal
Clone: B01-94-11M-P
Source: Mouse
Tissue Type/Cancer Type: Colon Ca